Xenetic Biosciences Inc (XBIO)
NASDAQ NMS - GLOBAL MARKET · Biotechnology
$2.500.00 (0.00%)Quote refreshed
Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires
Market Cap
$7.0M
P/E (TTM)
—
EPS
—
Div Yield
—
52W Range
—
Beta
—
Company overview
No company overview is available for Xenetic Biosciences Inc yet.
Peers in Biotechnology
All in industry →VRTX#1
Vertex Pharmaceuticals Incorporated
$113.64B+0.64%
REGN#2
Regeneron Pharmaceuticals, Inc.
$78.80B-0.99%
ARGX#3
argenx SE
$49.22B+1.97%
ALNY#4
Alnylam Pharmaceuticals, Inc.
$42.61B-1.82%
ONC#5
BeOne Medicines AG
$34.75B+0.39%
INSM#6
Insmed Incorporated
$34.45B-0.37%
RPRX#7
Royalty Pharma plc
$27.86B+0.84%
BNTX#8
BioNTech SE
$23.26B-0.11%
ROIV#9
Roivant Sciences Ltd.
$20.38B+1.10%
MRNA#10
Moderna, Inc.
$20.34B-1.57%
Recent press releases
Xenetic Biosciences Inc has not issued a press release in this window.
SEC filings
All filings →Xenetic Biosciences Inc has not filed an SEC document in this window.
Insider trades
All insider trades →Xenetic Biosciences Inc has no reported insider trades in the last 90 days.
Institutional holders
All holders →As of 2025-12-31 · prior 2025-09-30
RENAISSANCE TECHNOLOGIES LLC$387,365
178,509 sh+516.6%
CITADEL ADVISORS LLC$32,287
14,879 sh● NEW
DRW Securities, LLC$29,998
13,824 sh● NEW
4,012 sh● NEW
13,581 sh+27.1%
CITIGROUP INC$2,693
1,241 sh● NEW
25 sh0.0%
3 sh-25.0%
People at Xenetic Biosciences Inc
All people →Quarterly financials
Full financials →Revenue trend
03/25
$593.3K
NI -$903.1K
06/25
—
NI -$688.7K
09/25
$1.0M
NI -$509.9K
RevenueNI = Net Income
EPS trend (diluted)
Latest: $-0.33
Prior: $-0.45
Revenue sparkline